Tackling Ethical Challenges of Premature Delivery of Stem Cell-Based Therapies: ISSCR 2018 Annual Meeting Focus Session Report
Clinical uses of unproven stem cell-based interventions abound, yet many patients may be harmed by receiving them, raising complex ethical, economic, and societal concerns. Regulators, scientists, clinicians, professional societies, and patient advocacy groups need to collaboratively articulate expe...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-11-01
|
Series: | Stem Cell Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213671118304430 |
_version_ | 1818032104872607744 |
---|---|
author | Jeremy Sugarman Roger A. Barker Ian Kerridge Tamra Lysaght Graziella Pellegrini Douglas Sipp Claire Tanner |
author_facet | Jeremy Sugarman Roger A. Barker Ian Kerridge Tamra Lysaght Graziella Pellegrini Douglas Sipp Claire Tanner |
author_sort | Jeremy Sugarman |
collection | DOAJ |
description | Clinical uses of unproven stem cell-based interventions abound, yet many patients may be harmed by receiving them, raising complex ethical, economic, and societal concerns. Regulators, scientists, clinicians, professional societies, and patient advocacy groups need to collaboratively articulate expectations related to the proper development and delivery of stem cell-based therapies. : Clinical uses of unproven stem cell-based interventions abound, yet many patients may be harmed by receiving them, raising complex ethical, economic, and societal concerns. Regulators, scientists, clinicians, professional societies, and patient advocacy groups need to collaboratively articulate expectations related to the proper development and delivery of stem cell-based therapies. |
first_indexed | 2024-12-10T06:02:04Z |
format | Article |
id | doaj.art-abf0ce7276fb40e58fd67d6679d3afa6 |
institution | Directory Open Access Journal |
issn | 2213-6711 |
language | English |
last_indexed | 2024-12-10T06:02:04Z |
publishDate | 2018-11-01 |
publisher | Elsevier |
record_format | Article |
series | Stem Cell Reports |
spelling | doaj.art-abf0ce7276fb40e58fd67d6679d3afa62022-12-22T01:59:48ZengElsevierStem Cell Reports2213-67112018-11-0111510211025Tackling Ethical Challenges of Premature Delivery of Stem Cell-Based Therapies: ISSCR 2018 Annual Meeting Focus Session ReportJeremy Sugarman0Roger A. Barker1Ian Kerridge2Tamra Lysaght3Graziella Pellegrini4Douglas Sipp5Claire Tanner6Berman Bioethics Institute and Department of Medicine, Johns Hopkins University, Baltimore, MD, USA; Corresponding authorJohn van Geest Centre for Brain Repair and Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UKSydney Health Ethics, University of Sydney, Sydney, NSW, AustraliaCentre for Biomedical Ethics, National University of SingaporeCentre for Regenerative Medicine, University of Modena and Reggio Emilia, Modena MO, ItalyRiken Center for Biosystems Dynamics Research and Keio University School of Medicine/Global Research Institute, Tokyo, JapanThe Centre for Stem Cell Systems (ELSI program), The University of Melbourne, Parkville, VIC, AustraliaClinical uses of unproven stem cell-based interventions abound, yet many patients may be harmed by receiving them, raising complex ethical, economic, and societal concerns. Regulators, scientists, clinicians, professional societies, and patient advocacy groups need to collaboratively articulate expectations related to the proper development and delivery of stem cell-based therapies. : Clinical uses of unproven stem cell-based interventions abound, yet many patients may be harmed by receiving them, raising complex ethical, economic, and societal concerns. Regulators, scientists, clinicians, professional societies, and patient advocacy groups need to collaboratively articulate expectations related to the proper development and delivery of stem cell-based therapies.http://www.sciencedirect.com/science/article/pii/S2213671118304430 |
spellingShingle | Jeremy Sugarman Roger A. Barker Ian Kerridge Tamra Lysaght Graziella Pellegrini Douglas Sipp Claire Tanner Tackling Ethical Challenges of Premature Delivery of Stem Cell-Based Therapies: ISSCR 2018 Annual Meeting Focus Session Report Stem Cell Reports |
title | Tackling Ethical Challenges of Premature Delivery of Stem Cell-Based Therapies: ISSCR 2018 Annual Meeting Focus Session Report |
title_full | Tackling Ethical Challenges of Premature Delivery of Stem Cell-Based Therapies: ISSCR 2018 Annual Meeting Focus Session Report |
title_fullStr | Tackling Ethical Challenges of Premature Delivery of Stem Cell-Based Therapies: ISSCR 2018 Annual Meeting Focus Session Report |
title_full_unstemmed | Tackling Ethical Challenges of Premature Delivery of Stem Cell-Based Therapies: ISSCR 2018 Annual Meeting Focus Session Report |
title_short | Tackling Ethical Challenges of Premature Delivery of Stem Cell-Based Therapies: ISSCR 2018 Annual Meeting Focus Session Report |
title_sort | tackling ethical challenges of premature delivery of stem cell based therapies isscr 2018 annual meeting focus session report |
url | http://www.sciencedirect.com/science/article/pii/S2213671118304430 |
work_keys_str_mv | AT jeremysugarman tacklingethicalchallengesofprematuredeliveryofstemcellbasedtherapiesisscr2018annualmeetingfocussessionreport AT rogerabarker tacklingethicalchallengesofprematuredeliveryofstemcellbasedtherapiesisscr2018annualmeetingfocussessionreport AT iankerridge tacklingethicalchallengesofprematuredeliveryofstemcellbasedtherapiesisscr2018annualmeetingfocussessionreport AT tamralysaght tacklingethicalchallengesofprematuredeliveryofstemcellbasedtherapiesisscr2018annualmeetingfocussessionreport AT graziellapellegrini tacklingethicalchallengesofprematuredeliveryofstemcellbasedtherapiesisscr2018annualmeetingfocussessionreport AT douglassipp tacklingethicalchallengesofprematuredeliveryofstemcellbasedtherapiesisscr2018annualmeetingfocussessionreport AT clairetanner tacklingethicalchallengesofprematuredeliveryofstemcellbasedtherapiesisscr2018annualmeetingfocussessionreport |